Q1 2026 13F · SEC CIK 2074098
Taproot Management LP
Investment managerFiled 2026-05-13 for Q1 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $529.7M
- Reported positions
- 180
- Holdings vs S&P 500, 3 yrs
- —
- Average holding period
- 1 qtrs
Taproot Management LP is an investment manager that reported 180 positions worth $529.7M in its Q1 2026 13F, filed 2026-05-13. Its largest holdings were Performance Food Group Co (PFGC, 2.1%), West Pharmaceutical Svsc Inc (WST, 2.1%), Elevance Health Inc Formerly (ELV, 1.8%).
Taproot Management LP holdings largest 50 of 180 positions.
Weights are shares of the filer's total reported 13F value, compared with Q4 2025. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Taproot Management LP bought and sold in Q1 2026, against Q4 2025.
New positions
Q4 2025's filing was too long to tell new positions apart.
Added to
- AMH American Homes 4 Rent+19.8% shares
Reduced
- WAB Wabtec-68.4% shares
- RPRX Royalty Pharma PLC-54.5% shares
- ITT Itt-47.6% shares
- H Hyatt Hotels Corp-45.2% shares
- MTD Mettler Toledo International-43.2% shares
- CVS Cvs Health Corp-40.9% shares
- AHR American Healthcare REIT Inc-39.0% shares
- STZ Constellation Brands Inc-21.4% shares
Left the top 50
- CNI Canadian Natl Ry Cowas 2.0%
- BSX Boston Scientific Corpwas 1.8%
- SNYNF Sanofi SAwas 1.7%
- MDT Medtronic PLCwas 1.6%
- JBL Jabil Incwas 1.6%
- FDS Factset Resh Sys Incwas 1.6%
- GEV Ge Vernova Incwas 1.6%
- FDX Fedex Corpwas 1.6%
Share counts compared with the Q4 2025 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- —
- 3 years
- —
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q1 2026 | $529.7M | 180 |
| Q4 2025 | $617.3M | 147 |
Questions about Taproot Management LP's portfolio
What stocks does Taproot Management LP own?
Taproot Management LP's latest 13F, for Q1 2026 and filed May 13, 2026, lists 180 positions worth $529.7M. The largest are Performance Food Group Co (PFGC) at 2.1%, West Pharmaceutical Svsc Inc (WST) at 2.1%, Elevance Health Inc Formerly (ELV) at 1.8%, Thermo Fisher Scientific Inc (TMO) at 1.8% and AvalonBay Communities Inc (AVB) at 1.6%.
What did Taproot Management LP buy last quarter?
In Q1 2026, Taproot Management LP added American Homes 4 Rent (AMH) (+19.8% shares), compared with its Q4 2025 filing.
What did Taproot Management LP sell last quarter?
In Q1 2026, Taproot Management LP cut from its top 50 Canadian Natl Ry Co (CNI), cut from its top 50 Boston Scientific Corp (BSX), cut from its top 50 Sanofi SA (SNYNF), cut from its top 50 Medtronic PLC (MDT), cut from its top 50 Jabil Inc (JBL), Wabtec (WAB) (-68.4% shares), Royalty Pharma PLC (RPRX) (-54.5% shares) and Itt (ITT) (-47.6% shares), compared with its Q4 2025 filing.
When is Taproot Management LP's next 13F filing due?
13F filings are due 45 days after each quarter ends. Taproot Management LP's filing for the quarter ending Jun 30, 2026 was due by Aug 14, 2026; this page updates once it is processed.